Understanding Seasonal Flu
What is Seasonal Flu?
Seasonal flu is an acute respiratory infection caused by influenza viruses that are prevalent worldwide. Common symptoms include fever, cough, headache, muscle pain, sore throat, and a runny nose. Most individuals recover from these symptoms within a week without needing medical intervention. However, hospitalization and fatalities can occur among high-risk populations, including children, the elderly, pregnant women, and individuals with chronic health conditions.
Impact of Seasonal Flu
The World Health Organization estimates that seasonal flu results in 3 to 5 million cases of severe illness globally each year, leading to approximately 290,000 to 650,000 deaths annually. Vaccination remains one of the most effective strategies for preventing the flu. Given the ever-changing nature of flu viruses, vaccines must be reformulated each year to effectively target mutated viral proteins and various strains.
Innovations in Flu Vaccination
Introduction of a Universal Flu Vaccine
To enhance protection against multiple viral strains, researchers at the University of Pennsylvania have developed a universal modified-RNA flu vaccine. This innovative approach stimulates a robust antibody response to a component on the surface of flu viruses known as the hemagglutinin stalk. Upon injection, the modified RNA is taken up by immune system cells, which then produce hemagglutinin protein copies, simulating a natural flu infection and triggering a strong protective antibody response.
Advantages of New Vaccine Technology
Notably, these universal flu vaccines do not depend on the traditional chicken egg-based manufacturing process that has been in use for over 70 years. This advancement allows for a more scalable, cost-effective, and safer manufacturing method for flu vaccines. The research received backing from the National Institute of Allergy and Infectious Diseases and the Centers for Influenza Virus Research and Surveillance, with findings published in *Nature Communications*.
Animal Studies and Antibody Response
Further investigations involved animal studies to assess antibody responses. Following a single injection of the new universal flu vaccine, the animal subjects demonstrated a strong immune response to various flu virus strains, including H5N1. This novel vaccine approach promises to reshape the future of seasonal flu protection by offering a more potent effect through a combination of antigens. Additional clinical trials are necessary to thoroughly evaluate the safety and efficacy of these vaccines before they are made available to the public.
Reference
Pardi, N. et al. Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies. *Nature Communications*. 2018;9:3361. DOI: 10.1038/s41467-018-05482-0.